ArticleNature communications2026

Distinct multi-omics signatures of clinical subgroups of type 2 diabetes define heterogeneous responses to an insulin sensitizer.

Zehui Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.